Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factor-VIII consumption in pre-eclampsia

C W Redman, K W Denson, L J Beilin

    Lancet (London, England)
    |December 17, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    HLA-DR is aberrantly expressed at feto-maternal interface in pre-eclampsia.

    Journal of reproductive immunology·2018
    Same author

    Angiogenic factors: potential to change clinical practice in pre-eclampsia?

    BJOG : an international journal of obstetrics and gynaecology·2017
    Same author

    Trophoblast Glycoprotein (TPGB/5T4) in Human Placenta: Expression, Regulation, and Presence in Extracellular Microvesicles and Exosomes.

    Reproductive sciences (Thousand Oaks, Calif.)·2017
    Same author

    Pre-eclampsia: Definitions, paternal contributions and a four stage model.

    Pregnancy hypertension·2015
    Same author

    OS100. Plasma placental growth factor (PLGF) measurement in women presenting with suspected pre-eclampsia: the pelican study.

    Pregnancy hypertension·2015
    Same author

    Isolation of syncytiotrophoblast microvesicles and exosomes and their characterisation by multicolour flow cytometry and fluorescence Nanoparticle Tracking Analysis.

    Methods (San Diego, Calif.)·2015
    Same journal

    Convergence of metabolic risk in obesity and normal BMI: does risk disappear?

    Lancet (London, England)·2026
    Same journal

    Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

    Lancet (London, England)·2026
    Same journal

    Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

    Lancet (London, England)·2026
    Same journal

    The US Ebola response and the future of global health leadership.

    Lancet (London, England)·2026
    Same journal

    Daniel Mason: a tale of change.

    Lancet (London, England)·2026
    Same journal

    The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

    Lancet (London, England)·2026
    See all related articles

    Increased factor-VIII consumption in high-risk pregnancies correlates with pre-eclampsia severity. This coagulation abnormality may precede hyperuricemia and indicate a broader spectrum of pre-eclampsia beyond hypertension.

    Area of Science:

    • Obstetrics and Gynecology
    • Hematology
    • Nephrology

    Background:

    • Pre-eclampsia is a serious pregnancy complication characterized by hypertension and proteinuria.
    • Coagulation abnormalities are increasingly recognized as part of pre-eclampsia pathophysiology.
    • The relationship between coagulation factor consumption and pre-eclampsia severity requires further elucidation.

    Purpose of the Study:

    • To investigate the correlation between factor-VIII consumption and pre-eclampsia severity in high-risk pregnancies.
    • To determine the temporal relationship between factor-VIII consumption and hyperuricemia.
    • To explore the potential for a non-hypertensive syndrome encompassing pre-eclampsia-like renal and coagulation changes.

    Main Methods:

    • Studied 50 women with high-risk pregnancies.

    Related Experiment Videos

  • Assessed factor-VIII consumption by comparing factor-VIII-related antigen and factor-VIII clotting activity.
  • Monitored plasma-urate levels and other renal and coagulation parameters longitudinally.
  • Evaluated the effect of heparin and dipyridamole on coagulation abnormalities.

    • Main Results:

    • Increased factor-VIII consumption correlated with pre-eclampsia severity, particularly with elevated plasma-urate.
    • Factor-VIII consumption often preceded hyperuricemia, sometimes as early as 18 weeks' gestation.
    • Heparin and dipyridamole did not reverse the coagulation defect.
    • A case demonstrated pre-eclampsia-like renal and coagulation changes without hypertension.

    Conclusions:

    • Factor-VIII consumption is a significant indicator of pre-eclampsia severity.
    • The development of factor-VIII consumption may precede other clinical signs of pre-eclampsia.
    • The definition of pre-eclampsia may need to be expanded to include non-hypertensive conditions with similar renal and coagulation disturbances.